Cliquet F, Sagné L, Schereffer J L, Aubert M F
AFSSA Nancy, Laboratoire d'études sur la rage et la pathologie des animaux sauvages, B.P. 9, 54220 Malzéville, France.
Vaccine. 2000 Aug 1;18(28):3272-9. doi: 10.1016/s0264-410x(00)00127-4.
The assessment of the efficacy of rabies oral vaccination campaigns requires the titration of specific antibodies in the target species. Unfortunately, in Continental Europe, most fox serum samples are in fact "body fluids" taken from cadavers and the lack of a validated titration method for these poor quality sera made it impossible to survey and compare the efficacy of various oral vaccination protocols used by the different European teams. By using ready to use microplates sensitised with rabies virus glycoprotein purchased from a manufacturer and applying a simple and rapid ELISA technique on field fox sera, we obtained antibody quantitation highly correlated with seroneutralising antibody titres measured with a seroneutralisation test on cell culture. We obtained, with fox sera sampled in the same area, the same distribution of high, medium and low titres within all categories of serum quality (from high to very poor quality) and therefore conclude that this ELISA test allows a reliable titration even with highly contaminated body fluids. This test was shown to be equally capable of detecting rabies antibodies in serum samples taken from foxes vaccinated with an highly attenuated rabies virus (the SAG2 double mutant of the Street Alabama Dufferin strain) or with the VRG, the Vaccinia recombinant glycoprotein. Additionally, a strong correlation was demonstrated between titres given by this ELISA (or by the seroneutralisation test) and protection against challenge of foxes orally vaccinated with SAG2 vaccine baits. In view of this validation, this simple and reliable test is proposed for sero-surveying foxes following rabies oral vaccination campaigns.
评估狂犬病口服疫苗接种活动的效果需要对目标物种中的特异性抗体进行滴定。不幸的是,在欧洲大陆,大多数狐狸血清样本实际上是从尸体上采集的“体液”,而且缺乏针对这些质量较差血清的有效滴定方法,这使得无法对不同欧洲团队使用的各种口服疫苗接种方案的效果进行调查和比较。通过使用从制造商处购买的用狂犬病病毒糖蛋白致敏的即用型微孔板,并对野外狐狸血清应用简单快速的酶联免疫吸附测定(ELISA)技术,我们获得了与在细胞培养中通过血清中和试验测得的血清中和抗体滴度高度相关的抗体定量结果。我们在同一地区采集的狐狸血清中发现,在所有血清质量类别(从高质量到质量极差)中,高、中、低滴度的分布情况相同,因此得出结论,即使是对于高度污染的体液,这种ELISA检测也能进行可靠的滴定。结果表明,该检测同样能够在接种高度减毒狂犬病病毒(街阿拉巴马达弗林毒株的SAG2双突变体)或痘苗重组糖蛋白VRG的狐狸血清样本中检测到狂犬病抗体。此外,该ELISA(或血清中和试验)给出的滴度与用SAG2疫苗诱饵口服接种的狐狸抵抗攻击的能力之间存在很强的相关性。鉴于此验证结果,建议在狂犬病口服疫苗接种活动后使用这种简单可靠的检测方法对狐狸进行血清学调查。